Skip to main navigation

Investors
News & Media
- News Releases
Healthcare Professionals
Careers

Search for:

Search for:

About Acadia
About Acadia

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years, we have been working at the forefront of healthcare to bring vital solutions to people who need them most.
Learn More
Our Medicines

Our Medicines

Learn more about our FDA-approved treatments for Parkinson’s Disease Psychosis and Rett syndrome.

NUPLAZID® (pimavanserin)

DAYBUE™ (trofinetide)
Pipeline
Therapeutic Areas
Therapeutic Areas

At Acadia, we see promise in therapeutic areas where the unmet need remains high.
Learn More
Patients
Perspectives
Resources
Resources

At Acadia, we provide resources to further advance the innovative work of industry leaders, strategic partners and rigorous clinicians.

About Acadia
Back
About Acadia
Our Medicines

Back

Our Medicines
Pipeline
Therapeutic Areas
Back
Therapeutic Areas
Patients
Perspectives
Resources
Back
Resources
Investors
Back
Investors
News & Media
Back
News & Media
- News Releases
Healthcare Professionals
Back
Healthcare Professionals
Careers
Back
Careers

Investors › Gregory Renza

Biography

Stock
- Stock Information
- Analyst Coverage
News & Events
- News Releases
- Events & Presentations
Financials
- SEC Filings
- Annual Report and Proxy
Governance
Resources
- Email Alerts
- Information Request

Gregory Renza, M.D.

RBC Capital Markets

Investors Contact

Click here to contact Investor Relations.

Investor Contact

Email Alerts

Click here to sign up for email alerts.

© 2023 Acadia Pharmaceuticals Inc. Acadia and NUPLAZID are registered trademarks of Acadia Pharmaceuticals Inc. All rights reserved.

Privacy Policy
Privacy Shield
Compliance
Accessibility
Community Guidelines
Contact Us

LinkedIn
Twitter

Sitemap
Terms of Use
Cookies Policy

This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our Cookie Policy.